These benefits, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the principle of targeting ACKR3 as a unique strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-connected Conditions. These outcomes propose that conolidine https://pearlq664teh4.tdlwiki.com/user